The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs
Akin Akinc(Alnylam Pharmaceuticals (United States)), Pieter R. Cullis(University of British Columbia), Barbara L. Mui(Arbutus Biopharma (Canada)), Xinyao Du(Acuitas Therapeutics (Canada)), Sean C. Semple(Arbutus Biopharma (Canada)), Dominik Witzigmann(FPInnovations), Muthusamy Jayaraman(Alnylam Pharmaceuticals (United States)), Roy van der Meel(Eindhoven University of Technology), Ying K. Tam(Arbutus Biopharma (Canada)), Martin A. Maier(Alnylam Pharmaceuticals (United States)), Marco A. Ciufolini(FPInnovations), Muthiah Manoharan(Alnylam Pharmaceuticals (United States)), Michael J. Hope(Acuitas Therapeutics (Canada)), Steven M. Ansell(Acuitas Therapeutics (Canada)), Kevin Fitzgerald(Epsilon Systems (United States)), Jayesh A. Kulkarni(University of British Columbia), Thomas D. Madden(Arbutus Biopharma (Canada)), Scott Barros(Alnylam Pharmaceuticals (United States))
Cited by 1,559
Related Papers
Liposomal drug delivery systems: From concept to clinical applications
|Advanced Drug Delivery Reviews|2012|4.7k
Drug Delivery Systems: Entering the Mainstream
|Science|2004|4.5k
Production of large unilamellar vesicles by a rapid extrusion procedure. Characterization of size distribution, trapped volume and ability to maintain a membrane potential
|Biochimica et Biophysica Acta (BBA) - Biomembranes|1985|2.1k
Lipid polymorphism and the functional roles of lipids in biological membranes
|Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes|1979|1.8k
Rational design of cationic lipids for siRNA delivery
|Nature Biotechnology|2010|1.8k